Merck (MRK) Balance Sheet

Click line-items for a historical chart and %

Current Assets
Cash and cash equivalents	6.63B
Short-term investments	293.1M
Accounts receivable (including non-trade receivables of $571.0 in 2009 and $871.2 in 2008)	3.28B
Inventories (excludes inventories of $846.7 in 2009 and $587.3 in 2008 classified in Other assets - see Note 8)	2.15B
Deferred income taxes and other current assets	2.1B
Total current assets	15.49B
Investments	430.3M
Property, Plant and Equipment, at cost, net of allowance for depreciation of $12,358.0 in 2009 and $12,128.6 in 2008	11.65B
Goodwill	1.44B
Other Intangibles, Net	523.2M
Other Assets	5.15B
Total Assets	41.75B
Current Liabilities
Loans payable and current portion of long-term debt	450.5M
Trade accounts payable	646.8M
Accrued and other current liabilities	5.48B
Income taxes payable	583.7M
Dividends payable	0
Total current liabilities	8.02B
Long-Term Debt	8.07B
Deferred Income Taxes and Noncurrent Liabilities
Merck & Co., Inc. Stockholders' Equity
Common stock, one cent par value Authorized - 5,400,000,000 shares Issued - 2,983,508,675 shares
Other paid-in capital
Retained earnings	37.64B
Accumulated other comprehensive loss	-2.57B
Stockholders' equity before deduction for treasury stock	43.76B
Less treasury stock, at cost 874,330,563 shares at September 30, 2009 875,818,333 shares at December 31, 2008	0
Total Merck & Co., Inc. stockholders' equity	15.87B
Noncontrolling Interests	2.41B
Total Equity	18.28B
Total Liabilities and Stockholders' Equity	41.75B

Entities mentioned with MRK